Physician

Grace Marie Snyder, M.D.

According to 2025 Medicare claims, Grace Snyder, M.D. (NPI: 1518283688) practices nephrology in the Laredo, TX market, with the plurality of this provider's patient population coming from Webb, TX. This provider's primary affiliated billing organization is LAREDO NEPHROLOGISTS PLLC (NPI: 1295075927; TIN: 462049200) and primary practice location at 78043-4741. Snyder is affiliated with the UT Health San Antonio Regional Physician Network (ACO ID: A4678) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Snyder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 360 traditional Medicare patients, billed 1,521 HCPCS/CPT codes, and received $191,347 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,652 prescription claims across 304 beneficiaries totaling $512,303 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 134 claims. Open Payments data shows 5 records totaling $181. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $21,448 to $512,303. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$180K$360K2016 Medicare payment: $45,083 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $140,812 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $108,077 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $205,935 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $360,160 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $355,304 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $285,702 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $210,159 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $191,347 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201687652$45,083
20173332,424$140,812
20183392,137$108,077
20196263,266$205,935
20206482,812$360,160
20215802,371$355,304
20225592,042$285,702
20235021,511$210,159
20243601,521$191,347

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$260K$521K2015 Drug cost: $21,448 (USD; Tot_Drug_Cst)2016 Drug cost: $24,487 (USD; Tot_Drug_Cst)2017 Drug cost: $51,411 (USD; Tot_Drug_Cst)2018 Drug cost: $81,678 (USD; Tot_Drug_Cst)2019 Drug cost: $129,036 (USD; Tot_Drug_Cst)2020 Drug cost: $277,670 (USD; Tot_Drug_Cst)2021 Drug cost: $346,113 (USD; Tot_Drug_Cst)2022 Drug cost: $498,664 (USD; Tot_Drug_Cst)2023 Drug cost: $520,713 (USD; Tot_Drug_Cst)2024 Drug cost: $512,303 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151799$21,448
20162062$24,487
201777263$51,411
2018112566$81,678
2019148633$129,036
2020209813$277,670
2021222890$346,113
20222551,300$498,664
20232741,292$520,713
20243041,652$512,303

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.5K$5.0K2020 Medicare payment: $4,955 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,855 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,421 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,823 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R143$4,955
2021N/R159$3,855
2022N/R208$3,988
2023N/R166$2,421
2024N/R134$1,823

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90960Dialysis services, 4 or more physician visits per month (20 years or older)54396$267
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes5153$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more91213$64
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes156376$59
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's83170$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VelphoroSucroferric Oxyhydroxide391,470$116,161
FarxigaDapagliflozin Propanediol812,827$50,381
Sevelamer CarbonateSevelamer Carbonate1126,840$39,143
VeltassaPatiromer Calcium Sorbitex311,410$38,282
LokelmaSodium Zirconium Cyclosilicate321,038$22,539

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R36$607
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R35$414
J7507Tacrolimus, immediate release, oral, 1 mgNN/R37$412
J7517Mycophenolate mofetil, oral, 250 mgNN/R26$390

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$181AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Grace Marie Snyder, M.D.?

Tedicare shows public-source Medicare data for Grace Marie Snyder, M.D. (NPI 1518283688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Grace Marie Snyder, M.D. have ACO affiliation data?

Grace Marie Snyder, M.D. is shown with ACO affiliation data for UT Health San Antonio Regional Physician Network (MSSP, ACO ID A4678) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Grace Marie Snyder, M.D.?

Grace Marie Snyder, M.D. is linked to LAREDO NEPHROLOGISTS PLLC (billing NPI 1295075927) in the available physician profile data.

Does Grace Marie Snyder, M.D. have Open Payments data?

Grace Marie Snyder, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.